The Delhi High Court upheld FSSAI’s ban on ‘ORS’-labeled beverages, prioritising public health over commercial interests in Dr Reddy’s Laboratories’ challenge. HC refused interim relief for selling existing Rebalanz VITORS stock, directing rebranding proposals to FSSAI. The ruling stems from an 8-year campaign against misleading products deviating from WHO standards, affecting brands like ORSL.